Journal profile · Obstetrics & Gynecology
International Journal of Gynecological Cancer
ISSN 1048-891X · eISSN 1525-1438 · Wolters Kluwer Health · UNITED STATES · Monthly · Founded 1991
International Journal of Gynecological Cancer: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 5.43; hybrid open access; APC about USD 3,800; median 62 days to acceptance (97 articles, last 24 months); community-reported acceptance: easy; 2,367 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
International Journal of Gynecological Cancer is published by Wolters Kluwer Health and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment and Cervical Cancer and HPV Research, together about 56.6% of its articles. Its main subfields are Obstetrics and Gynecology. (generated from OpenAlex topic counts and CAS ranking data)
The International Journal of Gynecological Cancer, the official journal of the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology, is the primary educational and informational publication for topics relevant to detection, prevention, diagnosis, and treatment of gynecologic malignancies. IJGC emphasizes a multidisciplinary approach, and includes original research, reviews, and video articles. The audience consists of gynecologists, medical oncologists, radiation oncologists, radiologists, pathologists, and research scientists with a special interest in gynecological oncology.
Source: LetPub
Research area (LetPub): Obstetrics & Gynecology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Endometrial and Cervical Cancer TreatmentsMedicine24.5%
- Ovarian cancer diagnosis and treatmentMedicine21.8%
- Cervical Cancer and HPV ResearchMedicine10.3%
- Uterine Myomas and TreatmentsMedicine5.1%
- Intraperitoneal and Appendiceal MalignanciesMedicine4.1%
- Endometriosis Research and TreatmentMedicine3.1%
- Gynecological conditions and treatmentsMedicine3.1%
- PARP inhibition in cancer therapyMedicine3%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Obstetrics & Gynecology | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Oncology | Zone 3 |
| Minor | Obstetrics & Gynecology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Obstetrics & Gynecology | Zone 3 |
| Minor | Oncology | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.43LetPub ·
- CiteScore 2026-06
- 6.2LetPub ·
- SJR 2026-06
- 1.4LetPub ·
- SNIP 2026-06
- 1.54LetPub ·
- h-index
- 79LetPub ·
- h-index
- 124OpenAlex ·
- i10-index
- 4,909OpenAlex ·
- 2-year mean citedness
- 0.62OpenAlex ·
- Self-citation rate
- 11.1%LetPub ·
- Share of gold OA articles
- 17.64%LetPub ·
Volume
- Articles per year
- 282LetPub ·
Articles by year OpenAlex count · 23,905 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 1,813 | 129 | 163 |
| 2025 | 2,367 | 1,676 | 1,218 |
| 2024 | 2,196 | 2,167 | 2,572 |
| 2023 | 1,777 | 1,777 | 4,603 |
| 2022 | 1,880 | 1,880 | 3,910 |
| 2021 | 1,059 | 1,059 | 4,025 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
62 daysMedian, submission to acceptance · P25–P75 45 days – 81 days
- Acceptance to online
- median 7 days (97 articles)
- Submission to online
- median 70 days
- Sample
- 97 articles with submission and acceptance dates (1,105 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 3–6 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,800 / EUR 3,550 / GBP 3,040 / JPY 471,310 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Wolters Kluwer Health
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Monthly
- Founded
- 1991
- ISSN
- 1048-891X
- Electronic ISSN
- 1525-1438
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
FAQ
Frequently asked questions about International Journal of Gynecological Cancer
What CAS zone is International Journal of Gynecological Cancer in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Gynecological Cancer is in Zone 3 of Medicine, and in Zone 3 of the minor category Obstetrics & Gynecology / Oncology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Gynecological Cancer?
The latest impact factor listed by LetPub is 5.43; CiteScore 6.2, h-index 124.
How long does peer review take at International Journal of Gynecological Cancer?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 62 days (interquartile range 45–81 days); authors report an average review time of 3–6 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index International Journal of Gynecological Cancer?
According to LetPub and DOAJ records, International Journal of Gynecological Cancer is indexed in SCIE and Scopus.
Is International Journal of Gynecological Cancer open access, and what is the APC?
International Journal of Gynecological Cancer is a hybrid journal. For open-access publication: APC about USD 3,800.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-24). Last updated: .